These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 37078878)

  • 1. Cerebrospinal fluid: The new frontier for methylome-based diagnostic classification of brain tumors.
    Miller AM; Karajannis MA
    Neuro Oncol; 2023 Aug; 25(8):1461-1462. PubMed ID: 37078878
    [No Abstract]   [Full Text] [Related]  

  • 2. Diagnostic DNA methylome profiling and the WHO 5
    Frank S; Hench J
    Clin Neuropathol; 2022; 41(4):153-156. PubMed ID: 35670246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebrospinal fluid methylome-based liquid biopsies for accurate malignant brain neoplasm classification.
    Zuccato JA; Patil V; Mansouri S; Voisin M; Chakravarthy A; Shen SY; Nassiri F; Mikolajewicz N; Trifoi M; Skakodub A; Zacharia B; Glantz M; De Carvalho DD; Mansouri A; Zadeh G
    Neuro Oncol; 2023 Aug; 25(8):1452-1460. PubMed ID: 36455236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diagnostic value of the presence of neoplastic cells in the cerebrospinal fluid].
    DAUM S; GRUNER J
    Sem Hop; 1956 May; 32(27):1545-7. PubMed ID: 13324275
    [No Abstract]   [Full Text] [Related]  

  • 5. [Cerebrospinal fluid findings in brain tumors].
    Patzold U; Engelhardt P; Haller P
    Nervenarzt; 1975 Apr; 46(4):183-8. PubMed ID: 1178088
    [No Abstract]   [Full Text] [Related]  

  • 6. [Diagnostic assessment of cerebrospinal fluid protein in brain and spinal tumors].
    Kuppe G; Schmidt RM
    Psychiatr Neurol Med Psychol (Leipz); 1987 Oct; 39(10):613-7. PubMed ID: 3432440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CSF and laboratory analysis (tumor markers).
    Preusser M; Hainfellner JA
    Handb Clin Neurol; 2012; 104():143-8. PubMed ID: 22230441
    [No Abstract]   [Full Text] [Related]  

  • 8. Molecular tumor classification using DNA methylome analysis.
    Sill M; Plass C; Pfister SM; Lipka DB
    Hum Mol Genet; 2020 Oct; 29(R2):R205-R213. PubMed ID: 32657331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Studies on the changes in the composition of the cerebrospinal fluid in brain tumors with special consideration to the quantitative analysis of cerebrospinal fluid proteins].
    Bartko D; Danisová J; Wagnerová M
    Cesk Neurol; 1969 Jul; 32(4):175-82. PubMed ID: 5795004
    [No Abstract]   [Full Text] [Related]  

  • 10. [Cytomorphology of the cerebrospinal fluid. I. Tumors of the central nervous system (author's transl)].
    Castro A; Castillo J; Lema M; Cortés JA; Amigo MC; Noya M
    Med Clin (Barc); 1980 Oct; 75(7):301-5. PubMed ID: 7432038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of nonlinear dimension reduction of genome-wide DNA methylome in integrated diagnosis: A case study of glioblastoma, IDH-wildtype.
    Satomi K; Saito K; Shimoyamada H; Onizuka H; Shibayama T; Hibiya T; Hayashi A; Nagahama K; Yamagishi Y; Sasaki N; Kobayashi K; Gomyo M; Nagane M; Shibahara J
    Pathol Int; 2023 Oct; 73(10):523-526. PubMed ID: 37530489
    [No Abstract]   [Full Text] [Related]  

  • 12. [New diagnostic method for brain tumors by cell culture of the cerebrospinal fluid--Millipore filter-cell culture method].
    Nagai M; Tsuchida T; Hoshino T; Sano K
    Shinkei Kenkyu No Shimpo; 1967; 11(4):811-8. PubMed ID: 5627736
    [No Abstract]   [Full Text] [Related]  

  • 13. [Establishment of diagnostic model of cerebrospinal protein fingerprint pattern for glioma and its clinical application].
    Liu J; Zheng S; Yu JK; Yu XB; Liu WG; Zhang JM; Hu X
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2005 Mar; 34(2):141-7. PubMed ID: 15812888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebrospinal fluid microRNAs as diagnostic biomarkers in brain tumors.
    Kopkova A; Sana J; Fadrus P; Slaby O
    Clin Chem Lab Med; 2018 May; 56(6):869-879. PubMed ID: 29451858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Importance of cerebrospinal fluid spectrophotometry for the differential diagnosis of central nervous system tumors].
    Shevaga VN; Andriiuk LV; Besedin VN; Zastavnaia ; Romaniuk RG
    Vrach Delo; 1987 Sep; (9):82-4. PubMed ID: 3424783
    [No Abstract]   [Full Text] [Related]  

  • 16. [Preliminary note on cytological examination of the CSF in cerebral tumors in children. Diagnostic value. Prognostic value].
    Lapras C; Brunat M; Faucon M; Mansuy L
    Neurochirurgie; 1966; 12(5):580-3. PubMed ID: 5971255
    [No Abstract]   [Full Text] [Related]  

  • 17. [On the problem of the typical composition of cerebrospinal fluid proteins in brain tumors. Relation to the localization and character of the process].
    Bartko D; Danisová J; Wagnerová M
    Cas Lek Cesk; 1969 Apr; 108(18):533-40. PubMed ID: 5780761
    [No Abstract]   [Full Text] [Related]  

  • 18. Decoding the DNA methylome of central nervous system tumors: An emerging modality for integrated diagnosis.
    Satomi K; Ichimura K; Shibahara J
    Pathol Int; 2024 Feb; 74(2):51-67. PubMed ID: 38224248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Problems of the cytology and cytochemistry of the cerebrospinal fluid in tumors of the central nervous system].
    Pariante F
    Osp Psichiatr; 1968; 36(3):401-12. PubMed ID: 5733531
    [No Abstract]   [Full Text] [Related]  

  • 20. [Cerebrospinal fluid changes in brain tumors].
    Böcker F; Gross G
    Acta Neurochir (Wien); 1966; 15(1):28-32. PubMed ID: 4291482
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.